PCBP1 and breast carcinoma: As a member of the PCBP family proteins, PCBP1 is reported to be reduced in lung cancer, cervical cancer, breast cancer, colon cancer, and liver cancer [24–27], suggesting that altering PCBP1 expression may become a possible therapeutic strategy.